The Latin name of the homeopathic stock described in the marketing authorisation application dossier shall be in accordance with the Latin title of the European Pharmacopoeia or, in absence thereof, of an official pharmacopoeia of a Member State.
Beidh ainm Laidine an stoic hoiméapataigh a bhfuil tuairisc air sa sainchomhad iarratais ar údarú margaíochta i gcomhréir leis an teideal Laidine atá in Pharmacopoeia Eorpach nó, ina éagmais sin, in pharmacopoeia oifigiúil de chuid Ballstáit.